Cardiology

MS drug shows promise for preventing heart failure

A drug already approved to treat multiple sclerosis may also hold promise for treating cardiac hypertrophy, or thickening of the cardiac muscle—a disorder that often leads to heart failure, researchers at the University ...

Cardiology

Pathological thickening of the cardiac wall halted

The heart responds to the increased stress caused by chronically raised blood pressure, for example, by thickening its wall muscle. In the late stage of this condition, a risk of heart failure arises. Scientists from the ...

Cardiology

Researchers prevent heart failure in mice

(Medical Xpress)—Cardiac stress, for example a heart attack or high blood pressure, frequently leads to pathological heart growth and subsequently to heart failure. Two tiny RNA molecules play a key role in this detrimental ...

Cardiology

Risk of sudden cardiac death up for black patients with HTN

(HealthDay) -- Black patients with hypertension face a significantly increased risk of sudden cardiac death (SCD) compared with nonblack patients, even after adjusting for multiple confounding variables, according to a study ...

Cardiology

ESC calls for renaming of term cardiac hypertrophy

Sophia Antipolis, France: 27 June 2011: The European Society of Cardiology (ESC) Working Group on Myocardial Function is calling for a redefinition of the term cardiac hypertrophy which is currently used to describe changes ...

page 5 from 6